Samsung Biologics
207940.KS
$1,272
Share price
-0.19%
Change (1 day)
22.06%
Change (1 year)
Categories
Earnings for Samsung Biologics (207940.KS)
Earnings in 2024 (TTM): NZ$1.71 Billion
According to Samsung Biologics 's latest financial reports the company's current earnings are NZ$3.30 Billion. , an increase over its 2023 earnings that were of NZ$1.58 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Samsung Biologics from 2016 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | NZ$1.78 B | 12.65% |
| 2023 | NZ$1.58 B | 9.77% |
| 2022 | NZ$1.44 B | 67.66% |
| 2021 | NZ$0.86 B | 103.97% |
| 2020 | NZ$0.42 B | 57.39% |
| 2019 | NZ$0.26 B | -45.46% |
| 2018 | NZ$0.49 B | -390% |
| 2017 | -NZ$0.17 Billion | -46.74% |
| 2016 | -NZ$0.32 Billion |